Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Looking for ways to earn quick cash from home? Explore effective strategies that can help you increase your income easily.
21,939 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
California's new EV incentive is tilting the playing field for Rivian and Tesla. With Q1 results out, investors are w...
Palantir's Alex Karp has reignited the AI debate, arguing that the market overstates near-term gains from frontier mo...
A modest sale of 32 BTC by Strategy in late May upended assumptions about corporate Bitcoin buying, pushing investors...
Economist Peter Schiff argues that current Bitcoin holders could face regrets if they don’t cash out as BTC tests key...
Alphabet faces a pivotal year as AI monetization expands and cloud momentum compounds. Traders watch how capital spen...
Tech stocks lead a broad market pullback as AI costs rise and Netflix guidance misses, sending the Nasdaq Composite l...
AI stocks surged on hype, not just earnings. Yet after robust results from taiwan semiconductor and ASML, the market ...
Premium cinema formats are drawing crowds and lifting ticket revenues, signaling a shift in consumer budgets and thea...
Microsoft leans on three strategic ties—OpenAI, hardware collaboration with AMD, and Copilot enterprise adoption—to s...
As job cuts persist in early 2026, employers cite AI adoption to explain restructuring. The trend underscores why wor...
Palantir is betting big on an AI-first future. This article breaks down the strategy, what it could mean for investor...